CE-Ventures logo

CE-Ventures

Asia, Sharjah, United Arab Emirates, Sharjah

Description

CE-Ventures is the corporate venture capital platform of Crescent Enterprises.

Investor Profile

CE-Ventures has backed more than 6 startups, with 3 new investments in the last 12 months alone. The firm has led 4 rounds, about 67% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series C rounds (top funding stages).
  • Majority of deals are located in United States, India, France.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.
  • Led 2 rounds in the past year.

Stage Focus

  • Series A (33%)
  • Seed (33%)
  • Series C (17%)
  • Series B (17%)

Country Focus

  • United States (50%)
  • India (33%)
  • France (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Manufacturing
  • Medical
  • Life Science
  • Women's
  • Consumer Lending
  • Finance
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CE-Ventures frequently co-invest with?

Angelini Ventures
Europe, Lazio, Italy, Rome
Co-Investments: 1
B
North America, California, United States, San Bruno
Co-Investments: 1
Capital Grand Est
Europe, Alsace, France, Schiltigheim
Co-Investments: 1
UI Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Indaco Venture Partners
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Export and Investment Fund
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
McNair Interests
North America, Texas, United States, Houston
Co-Investments: 1
PV
North America, California, United States, Del Mar
Co-Investments: 1
Corundum Systems Biology
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

Which angels does CE-Ventures often collaborate with?

Shared Deals: 1
SL
North America, California, United States, San Francisco
Shared Deals: 1
Nandan Reddy
Asia, Karnataka, India, Bengaluru
Shared Deals: 1
AK
Asia, Maharashtra, India, Mumbai
Shared Deals: 1

What are some of recent deals done by CE-Ventures?

Think Bioscience

Boulder, Colorado, United States

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

BiotechnologyLife ScienceTherapeutics
Series AJan 20, 2026
Amount Raised: $55,000,000
Distil

Mumbai, Maharashtra, India

Distil appreciate the necessity of identifying novel chemicals and ensuring a continuous supply of consistent quality.

ChemicalWholesale
Series ASep 23, 2025
Amount Raised: $7,700,000
Mesh

San Francisco, California, United States

Mesh is a crypto payments network that creates a connected, secure crypto ecosystem with various integrations for businesses and users.

CryptocurrencyFinancial ServicesFinTechPayments
Series UnknownAug 14, 2025
PierSight Space

Ahmedabad, Gujarat, India

PierSight is constructing a SAR satellite network to provide continuous monitoring for the maritime industry.

Information TechnologySoftware
SeedMay 20, 2025
CrossBridge Bio

Houston, Texas, United States

CrossBridge Bio operates as a biotechnology company.

BiotechnologyTherapeutics
SeedNov 4, 2024
Amount Raised: $10,000,000
Basic Home Loan

Gurgaon, Haryana, India

Basic Home Loan is a FinTech company offering a mortgage distribution platform to automate loan process for prospective homeowners.

Consumer LendingFinanceFinancial ServicesFinTechReal Estate
Series BSep 30, 2024
Amount Raised: $10,437,784
Freya Biosciences

Boston, Massachusetts, United States

Freya Biosciences is a clinical-stage women’s health company pioneering a new class of microbial immunotherapies.

Life ScienceWomen's
Series ADec 12, 2023
Amount Raised: $38,000,000
EndoQuest Robotics

Houston, Texas, United States

EndoQuest Robotics is a medical cquipment manufacturing company that makes endoluminal robotic surgical system for medical industries.

Health CareManufacturingMedical
Series CDec 4, 2023
Amount Raised: $42,000,000
Exeliom

Dijon, Bourgogne, France

Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AJun 30, 2023
Amount Raised: $8,733,148

Find More Investors Like CE-Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides